Balyasny Asset Management Reports New 5.07% Stake in Camp4 Therapeutics Corp.

On May 15, 2026, Balyasny Asset Management L.P. (BAM) filed a Schedule 13G indicating a new 5.07% ownership stake in Camp4 Therapeutics Corp. (CAMP). The reporting persons, which include BAM, BAM GP LLC, Balyasny Asset Management Holdings LP, Dames GP LLC, and Dmitry Balyasny, reported beneficial ownership of 2,632,437 shares of common stock. The shares are held directly by Atlas Diversified Master Fund, Ltd (335,392 shares) and Atlas Private Holdings (Cayman) Ltd. (2,297,045 shares, including shares issuable upon warrant exercise). While the reporting persons hold warrants for an additional 1,624,523 shares, these are subject to a 4.99% beneficial ownership limitation blocker. Dmitry Balyasny, as the Managing Member of Dames GP LLC, may be deemed to exercise voting and investment power over the shares. This filing represents an initial passive investment position for the reporting group, as the securities were acquired in the ordinary course of business without the intent to change or influence control of the issuer.